CFI CIAL
DOCUMNTS
LOAN NUMBER 8934-IN
Loan Agreement
(Tamil Nadu Health System Reform Program)
between
INDIA
and
INTERNATIONAL BANK FOR RECONSTRUCTION
AND DEVELOPMENT
Public Disclosure Authorized
Public Disclosure Authorized
Public Disclosure Authorized
Public Disclosure Authorized
LOAN AGREEMENT
AGREEMENT dated as of the Signature Date between INDLA ("Borrower") and
INTERNATIONAL BANK FOR RECONSTRUCTION AND DEVELOPMENT ("Bank"). The
Borrower and the Bank hereby agree as follows:
ARTICLE I -
GENERAL CONDITIONS; DEFINITIONS
1.01. 
The General Conditions (as defined in the Appendix to this Agreement) apply to and form
part of this Agreement.
1.02. 
Unless the context requires otherwise, the capitalized terms used in this Agreement have
the meanings ascribed to them in the General Conditions or in the Appendix to this
Agreement.
ARTICLE II- LOAN
2.01. 
The Bank agrees to lend to the Borrower the amount of two hundred and eighty-seven
million dollars (USD 287,000,000), as such amount may be converted from time to time
through a Currency Conversion ("Loan"), to assist in financing the program described in
Schedule I to this Agreement ("Program").
2.02. 
The Borrower may withdraw the proceeds of the Loan in accordance with Section IV of
Schedule 2 to this Agreement. All withdrawals from the Loan Account shall be deposited
by the Bank into an account specified by the Borrower and acceptable to the Bank.
2.03 
The Front-end Fee is one quarter of one percent (0.25%) of the Loan amount.
2.04. 
The Commitment Charge is one quarter of one percent (0.25%) per annum on the
Unwithdrawn Loan Balance.
2.05, 
The interest rate is the Reference Rate plus the Variable Spread; or such rate as may apply
following a Conversion; subject to Section 3.02(e) of the General Conditions.
2.06. 
The Payment Dates are May 15 and November 15 in each year.
2.07. 
The principal amount of the Loan shall be repaid in accordance with Schedule 4 to this
Agreement.
2.08. 
(a) 
If on any given day, the Total Exposure exceeds the Standard Exposure Limit (as
said terms are defined in sub-paragraphs (b)(ii) and (b)(iii) of this Section), the
Borrower shall pay to the Bank a surcharge at the rate of one half of one percent
(0.5%) per annum of the Allocated Excess Exposure Amount (as defined in sub-
paragraph (b)(i) of this Section) for each said day ("Exposure Surcharge"). The
Exposure Surcharge (if any) shall be payable semi-annually in arrears on each
Payment Date.
(b) 
For purposes of this Section the following terms have the meanings set forth below:
-2-
(i) 
"Allocated Excess Exposure Amount" means for each day during which the
Total Exposure exceeds the Standard Exposure Limit, the product of (A) the
total amount of said excess; and (B) the ratio of all (or, if the Bank so
determines, a portion) of the Loan to the aggregate amount of all (or the
equivalent portions) of the loans made by the Bank to the Borrower, and to
other borrowers guaranteed by the Borrower that are also subject to an
exposure surcharge, as said excess and ratio are reasonably determined from
time to time by the Bank.
(ii) "Standard Exposure Limit" means the standard limit on the Bank's financial
exposure to the Borrower which, if exceeded, would subject the Loan to the
Exposure Surcharge, as determined from time to time by the Bank.
(iii) "Total Exposure" means for any given day, the Bank's total financial
exposure to the Borrower, as reasonably determined by the Bank.
ARTICLE II -
PROGRAM
3.01. 
The Borrower declares its commitment to the objectives of the Program. To this end, the
Borrower shall cause the Program to be carried out by the Program Implementing Entity
in accordance with the provisions of Article V of the General Conditions, Schedule 2 to
this Agreement and the Program Agreement.
ARTICLE IV -
EFFECTIVENESS; TERMINATION
4.01. 
The Effectiveness Deadline is the date ninety (90) days after the Signature Date.
ARTICLE V -
REPRESENTATIVE; ADDRESSES
5.01. 
The Borrower's Representative is any of the following officials acting severally: The
Secretary, Additional Secretary, Joint Secretary, Director. Deputy Secretary, or Under
Secretary of the Department of Economic Affairs of the Borrower's Ministry of Finance.
5.02. 
For purposes of Section 10.01 of the General Conditions:
(a) the Borrower's address is:
Secretary
Department of Economic Affairs
Ministry of Finance
Government of India
North Block
New Delhi 110 001. India; and
(b) the Borrower's Electronic Address is:
Facsimile: 
E-mail:
-91-11-23094075 
secy-dea@nic.in
5.03. 
For purposes of Section 10 01 of the General Conditions:
(a) 
the Bank's address is:
International Bank for Reconstruction and Development
1818 H Street, N.W.
Washington, D.C. 20433
United States of America; and
b) 
the Bank's Electronic Address is:
Facsimile:
1-202-477-6391
AGREED as of the Signature Date.
INDIA
By
Authorized Representative
Name: 
T 
Ar 
fte
Title: A-tsb-n0-A-7- 
-qZ1e 7174eJ
Date: 
JDC-'' 
L/ 
2-01,
INTERNATIONAL BANK FOR
RECONSTRUCTION AND DEVELOPMENT
By
Authorized Representative
N ame: 
M SJ-1 Ar-Y 
A16 D
Title: -Ar-7-A4 
CJ 
AI
7  
A.1b 14
Date: -MJU'..Lt 
o'
-4-
SCHEDULE I
Program Description
The objective of the Program is to improve quality of care, strengthen management of
NCDs and injuries, and reduce inequities in reproductive and child health services in Tamil Nadu.
The Program consists of the following parts:
Part A. Improved Quality of Care
1. 
Improvement in governance, through development of clinical protocols, guidelines.
monitoring of quality of care using facility dashboards, introduction and scaling up of
clinical governance and other quality improvement initiatives, and facility certification.
2. 
Support for certification of Primary Care Facilities and Secondary Care Facilities by
NQAS. and of Tertiary Care Facilities by NABH.
3. 
Expansion of continuous medical education program, and development of user-friendly
decision support tools for providers.
4. 
Engagement with the population, through developing and implementing patient experience
questionnaires, making quality and other data accessible to the public, and conducting
district and state health assemblies.
Part B. Strengthened Management of NCDs and Injuries
1. 
Improved management of NCDs, through support for:
(a) 
health promotion and NCD prevention, including development and implementation
of comprehensive social and behavior change communication strategy;
(b) 
population-based screening of NCDs, including through house visits and awareness-
raising;
(c) 
treatment and follow-up, including through establishment of health and wellness
centers, strengthening of Primary Health Centers, strengthening of lab services; and
strengthening of health provider capacity to address mental health;
(d) 
improved monitoring and evaluation, including through development of NCD care
cascades for selected tracer conditions and strengthening data on NCDs; and
(e) 
establishment of a multi-sectoral coordination mechanism to support state NCD
response.
2. 
Improved management of injuries by strengthening pre-hospital and in-hospital care,
including through:
(a) 
implementation of work plan 
for emergency medical services, 
including
strengthening of ambulance service, provision of 24x7 trauma care services and
establishment of a trauma registry. and
(b) 
training of emergency department trauma care providers and other health care
workers.
Part C. Reduced Equity Gaps in Reproductive and Child Health
1. 
Improving provision of reproductive and child health services.
2. 
Establishing maternity stay wards in remote areas.
3. 
Developing and implementing a social and behavior change communication strategy
tailored to Priority Districts.
Part D. Cross-Cutting Initiatives to Strengthen Institutional and State Capacity to Achieve
the Above Results
I. 
Strengthening the content, quality. accessibility and use of data and evidence for decision-
making, including through strengthening of HMIS, and support for operational research,
implementation research and health system research.
2. 
Enhancing transparency and accountability in health sector operation, including through
annual district and state health assemblies.
3. 
Strengthening of health administration and management, including improving integration
and coordination among health directorates and between centrally-sponsored schemes and
state-financed efforts.
-6-
SCHEDULE 2
Program Execution
Section I. 
Implementation Arran2ements
A. 
Institutional Arrangements
1I 
To facilitate the carrying out of the Program, the Borrower shall make the proceeds of the
Loan available to the Program Implementing Entity in accordance with the Borrower's
standard arrangements for developmental assistance to the states of India. Notwithstanding
the foregoing, in the event that any provision of this Agreement, including the instructions
that the Bank shall have specified by notice to the Borrower pursuant to Section 2.01(b) of
the General Conditions (including the Disbursement and Financial Information Letter),,
were to be found inconsistent with the Borrower's standard arrangements for development
assistance to the states of India, the provisions of this Agreement and aforesaid instructions
shall govern.
2. 
The Borrower shall at all times protect its own interests and the interests of the Bank to
accomplish the purposes of the Loan.
B. 
Program Action Plan
1 .
The Borrower shall cause the Program Implementing Entity to:
(a) 
implement the Program Action Plan agreed with the Bank, in a manner and
substance satisfactory to the Bank and
(b) 
refrain from amending, revising, waiving, voiding, suspending or abrogating, any
provision of the Program Action Plan, whether in whole or in part, without the
prior written concurrence of the Bank.
2. 
In the event of any inconsistency between the provision of the Program Action Plan and
those of this Agreement and/or the Program Agreement, the provision of the latter
agreement(s) shall govern.
C. 
Fiduciary, Environmental and Social Systems for the Program
Without limitation on the provisions of Article V of the General Conditions, the Borrower
shall cause the Program Implementing Entity to carry out the Program in accordance with
financial management, procurement and environmental and social management systems
acceptable to the Bank, including those set out in the ESSA and the Program Action Plan
("Program Fiduciary, Environmental and Social Systems") which are designed to ensure
that:
(a) 
the Loan proceeds are used for their intended purposes, with due attention to the
principles of economy, efficiency, effectiveness, transparency, and accountability;
and
(b) 
the actual and potential adverse environmental and social impacts of the Program
are identified, avoided, minimized, or mitigated, as the case may be, all through an
informed decision-making process.
Section I. 
Excluded Activities
The Borrower shall, through the Program Implementing Entity. ensure that the Program
excludes any activities which:
(a) 
in the opinion of the Bank, are likely to have significant adverse impacts that are
sensitive, diverse, or unprecedented on the environment and!or affected people; or
(b) 
involve the procurement of: (1) works, estimated to cost USD 115,000,000
equivalent or more per contract: (2) goods, and non-consulting services, estimated
to cost USD 75,000,000 equivalent or more per contract; or (3) consulting services,
estimated to cost USD 30,000,000 equivalent or more per contract.
Section M. 
Program Monitorinz, Reporting and Evaluation
A. 
Program Reports
The Borrower shall cause the Program Implementing Entity to furnish to the Bank each
Program Report not later than two months after the end of each fiscal semester, covering
the fiscal semester.
B. 
Verification Protocols
The Borrower shall cause the Program Implementing Entity to:
(a) 
undertake a verification process. in accordance with the terms of reference agreed
with the Bank, to certify the fulfillment of the Disbursement Linked Results
(DLRs) set out in Schedule 3 to this Agreement; and
(b) 
furnish to the Bank corresponding verification report(s), in form and substance
agreed with the Bank.
Section IV. 
Withdrawal of Loan Proceeds
A. 
General
1. 
Without limitation upon the provisions of Article II of the General Conditions and in
accordance with the Disbursement and Financial Information Letter, the Borrower may
withdraw the proceeds of the Loan to: (a) pay the Front-end Fee; (b) pay each Interest Rate
Cap or Interest Rate Collar premium; and (c) finance Program Expenditures, on the basis
of the DLRs achieved by the Program Implementing Entity, as measured against specific
indicators ("Disbursement Linked Indicators or DLIs"), as set forth in the table in
paragraph 2 of this Part A and Schedule 3 to this Agreement.
-8-
2. 
The following table specifies each category of withdrawal of the proceeds of the Loan
(including the DLls as applicable) ("Category") and the allocation of the amounts of the
Loan to each Category. Notwithstanding the foregoing, for purposes of Categories (1) to
(8) of the table below, the actual amounts authorized for disbursement ("Allocated
Amount") and or the formula for their determination upon the achievement of an individual
DLR for any given DLI financed under such Category, are set forth in Schedule 3 to this
Agreement:
Category 
Amount of the Loan
(including Disbursement Linked Indicator as applicable) 
1 
Allocated
(expressed in USD)
(1) DLI l: Implementation of quality improvement 
43,732,000
interventions in Primary, Secondary and Tertiary Care
Facilities
(2) DLI #2: Increased number of public facilities with quality 
38,200,000
certification (Primary, Secondary and Tertiary Care
Facilities)
(3) DLI #3: Increased share of adults with hypertension or 
48,885,500
diabetes whose blood pressure or blood sugar are under
control
(4) DLI #4: Improved provision of quality trauma care 
17,715,000
services
(5) DLI #5: Increased utilization of reproductive and child 
56,500,000
health services in Priority Districts
(6) DLI #6: Strengthened content, quality, accessibility and 
36,500,000
use of data for decision making
(7) DLI #7: Strengthened coordination, integration, 
30.750,000
performance-based management, learning and other cross-
cutting functions for better results
(8) DLI #8: Increased transparency and accountability 
14,000,000
through citizen engagement (voice, agency and social
accountability)
(9) Front-end Fee to be paid pursuant to Section 2.03 of this 
717,500
Agreement in accordance with Section 2.05 (b) of the General
Conditions
(10) Interest Rate Cap or Interest Rate Collar premium to be 
0
paid pursuant to Section 4.05 (c) of the General Conditions
TOTAL AMOLNT 
287,000,00
-9-
B. 
Withdrawal Conditions; Withdrawal Period
1I 
Notwithstanding the provisions of Part A of this Section, no withdrawal shall be made:
(a) 
on the basis of DLRs achieved prior to the Signature Date. except that withdrawals
-
up to an aggregate amount not to exceed USD 6,567,000 under Category (2) may
be made on the basis of DLRs achieved prior to this date but on or after November
16. 2018: or
(b) 
for any DLR until and unless the Borrower has furnished evidence satisfactory to
the Bank that said DLR has been achieved.
2. 
Notwithstanding the provisions of Part B. 1 of this Section, the Borrower may withdraw an
amount not to exceed S 71,750,000 as an advance for the purpose of achieving one or more
DLRs for which the Borrower shall subsequently furnish to the Bank the evidence referred
to in Part B. 1 of this Section; provided, however, that if the DLR(s) in the opinion of the
Bank, is/are not achieved (or only partially achieved) by the Closing Date, the Borrower
shall refund such advance (or portion of such advance as determined by the Bank in
accordance with the formula set forth for the Allocated Amount for such DLR(s) in the
matrix in Schedule 3 to this Agreement) to the Bank promptly upon notice thereof by the
Bank. Except as otherwise agreed with the Borrower, the Bank shall cancel the amount so
refunded. Any further withdrawals requested as an advance under any Category shall be
permitted only on such terms and conditions as the Bank shall specify by notice to the
Borrower.
3. 
Notwithstanding the provisions of Part B. I of this Section, if any of the DLRs has not been
achieved by the date by which the said DLR is set to be achieved, the Bank may, by notice
to the Borrower:
(a) 
authorize the withdrawal of such lesser amount of the unwithdrawn proceeds of
the Loan then allocated to the respective Category which, in the opinion of the
Bank, corresponds to the extent of achievement of said DLR, said lesser amount
to be calculated in accordance with the formula set out for the Allocated Amount
against such DLR under the matrix in Schedule 3 to this Agreement:
(b) 
reallocate all or a portion of the proceeds of the Loan then allocated to said DLR
to any other DLR; and/or
(c) 
cancel all or a portion of the proceeds of the Loan then allocated to said DLR.
4. 
The Closing Date is May 31, 2024.
: 
�, 
- _ 
�_ �_ 
.
} 
И
�: �
s 
, �' 
-С
V 
? 
_' 
.4 
т
ii 
S' 
у
.у' 
у
.�. 
I С
л
Г 1 q,% 
`ц
>+ 
7
�.
', 
` �
г_ 
�" v 
7 
.д
с
�
�
^J 
. �
. �
_й
� .N.
. 
�
�._' г �
�
q 
С
` 
U ... 
�
�
У
t. 
ь. ` 
�
�
С
'О
" �
�
, 
у
...
R 
�
�1 
N 
"` 
'О
w 
z 
�
а
`
�>' 
i1 
., 
х
�
�
2 М
« 
`�
4 
.. 
�
С
q t, 
:0 
3 
U
М
z 
Q 
N 
у
i �" 
..О
.�' �
+ 
!` 
'�
л
г,0 
С
у
- 
�
r 
�'
�
t 
ti 
- 
�
�
. 
С
3 
7 
L 
I � = ..�; 
�9 
�
U �
С . '1. 
'J
Q 
ьу. 
"О
Т
I.: д ьL .r 
И
7.`. 
�
... 
У '
�
.ь+с
; 
�
'. с
s 
л
�
с
:�
4 
= 
�
С
�
i 
5 
�
.�
�
л
4 
л
�
v.
�
�
У
Е
.^. i у 9 С � � �
Е
°ц
о .� 1.'. 
� =_ .., }
Q 
� . 
} 
v 
j 
г
з� ... 
>+ ' � �
й
и
'.>з
�д
Л
:_.
�
'-�
L 
�
._: 
С. 
�
,."'. 
.. 
.q 
�
,- 
�_ 
О
�
� у
> 
гП
_ 
ьу. 
`�
v 
Р . 
х ? 6 
? 
д
-.J 
_ 
С
."�-.
i+ 
.. 
i � N 
�
у
н
^ 
С
�.U6 Г 1 i'.
�О
i 
v 
С
... 
� .
R 
у
ь
Г`1 
л�
� ' 
У
Ср
О
1. 
Г 1 
'�
; г, 
,а
'�
7 
^^! 
.
�
Ч
�
N 
�
- 
- 
С
"�
r. 
... 
.. 
. _ 
�3 
и .
�
0.�
'�
в
ги _ b т
�
"' 
и
�
.`с и
.,�С
.'п у
Е
�
Е �
..
Q 
�
Q... т а
�
:о "v .- 
:а v. 
.- 
л
а
-- м
С
".,�',�
G 
= 
t 
�
�
л
в1 
�
у
У
м
�
С�С
`v ;�
ti>, 
.`'с
са
'_ 
R
�
.-=i.i 
т
г
ё
У
�
а
:д
>' 
�
а = v �
а
�
�а н
�-
й
CL�
и
с �
v
� г° 
а- 
.�
(; 
Е
л �
v 
л
v v q f-
у
^ 
_ 
С
' С
. С
р
�р
�
- 
�
� ' 
- 
t 
` �
'.:
, 
> 
N 
�
ь
'�
с,д
G 
�S 
:д
- 
�
:0 
�..! 
С" ... 
^'J'
. с
х
г!, 
т
.�
. 
' � ,л
�
�р - 
�
О
'W 
^1 
О
у
л
s 
�
�^ 
^ 
.
у
�
s
� о у - 
_ � �
I�
.. 
У
... 
У .�
� �
��
Е
х
N 
"`-° 
й
'� v г
'�
.'а
у
`°
гг; С
�
в
1:
г
а' 'v о
й
._. 
<�с :J 
-- 
�
л
� = у
;:; -а
г
--
� �
нт7 
" и
т
�. с
>` 
�
�
у
�
т �- н
�
° �- 
а = 
с
�
.:i 
�
�+ 
Л
'Yi 
'ii. 
�
L 
у
�
У
�
v 
��
cQ и
.
. 
�
.Г�. 
'S�, 
г
�
... 
Е
L � у
й
у
'se°. ^_ Т 'i
и
�
` с у
у
а' -°в о Е : 
�
" 
� °- � v
U 
с
л
Л
> ^. 
�
С
д ' 
С
у
^ 
`- 
'J 
^ 
�
^ 
�
�
.-'1-. �^..
�
�
N 
�
у
�
�
�
�
' 
`.. 
J 
О
..! 
!: 
г
и
�
'�: 
х
о
"' 
�' 
.. 
У
..? 
- о
у
а
_л
ер г
�
�
V' 
?
�
К
N 
у
�
- 
> 
.. 
^ 
�
`�
�
С й
�
°' 
й
.�
и
n�-i L з
:а г
_ �
г
�
с ос
й
т
�
'_ 
' 
с
� л I�
а
с
z. 
2 ьz. 
т
�' . 
.
�
з
С
. �
=�
}
и
i 
s 
i
�
г
�
..ci 
у
.+.
�
�7 
_ 
7i
�
�
L 
Ф
Л
>
у
д7 у. 
У
G 
�'"' 
у
.- 
._>.' 
. 
.ii 
- 
Q 
9 
'9 
� . 
и
- 
_
С. 
-` 
ш
�
'.�д
с
С
у
;а
':
7
�
Q 
у
у
�
'д
>
�
О
т
"�
у
" 
�
С
`�
С
т е�
=' 
�
R �
iб ^ L 
й
с
У
О
^ 
О
^ 
' О
�
. р
^ 
"' 
'�
.^ 
�
�
�
�
�
У
.�
N 
i 
С
'-л' ',�
ьС.. 
�
�
r(
�
�
й
_ 
й
i 
, 
3 
у
ro �Д
�
> 
'�
'' 
'^ 
_Л
U.
с
л
О ' �
д
:ь. 
к
о
v- 
,
�D ^7 
. 
у
И
�
.. �
I - 
.-..
�
. 
Qi 
1 
Z 
+r 
�
'в
О
�
�
а
�
Е" 
_О
> ^ О V 
�
�
С� - 
С � п у �
! 
�
�r] 
�
д
О� �
�
Q!
./�
б
, 
у
�
' 
- �
и
S 
^ 
` 
�
�
у
�
,, 
�
I 
ы
~
�.. 
.�.!
л
�
у
С ё
у � г
�
�
д г
� ' = С
6ri 
' 
�
_ 
1 
�
1
д
1 
�
:л
у
- 
�
>' 
V: 
t 
�
С
� . 
�
у
'7
� s �
_ 
�
х
��
L .ro 
�
�
�
�
и
с
-- 
А
�
�
Z 
Q 
3 
�
�
С
л
:а
Ч
r = >� .. 
з
^ 
3 �
¢ 
' с
^ �
�
.; 
'�
'�
. 
. 
�
�
N 
�b 
С
гw ° 
�- 
G 
��с
з
гл
.. �
�
у = г, 
j 
д
.� � * �
; j, 
'° 
v 
л
с
1 
�
_ 
г
N 
. 
z 
Q 
Г=у
. 
С
�с
�
�
�
�
�
( ы
J 
�
4 
..�.
:D
i L 
. 
t
�
�
�
�
..�
о
г
b 
�,р
С
.. 
I
а
�
�
_ 
n', �
3 j 
л
о
Е
.: 
о
�
= 
и
.х
г
�
�
" 
�
у � о
'. �> 
.с
�
�
- 
�
S 
,л, 
й
, 
л
�
о° 
r 
;и
" 
- 
�
'�
с
_ ' 
г' 
. 
- 
�
у
3 
=�
^ 
т
"3}� 5 
Д "= 
� �
'.,-.�и q 
х
� �
�
3 s 
л
q 
е`°i 1
г а
д_ s 
у �
Е с -_ 
у �; и
� �
�
s 
Е ',
�
` 
� . 
г . 
с
л
;�
�
> 
о
.а ;
у т ��
.�
3, 
: � �
� Е v' д
� � g- 
у
�
ё
q �
-_ и
- 
_ л
с �`�' 
`� т
� .. 
L п, с
s 
а
�
с
с 1
_ 
т
= N 
и
>' 
ы
�
и
n, 
�
" 
Е
_.. 
�
С. 
., 
Е
^ �о
о
с
� % 
.yr 
�
_ 
, 
'г�
Л
,иб
�й
.�
TYJ' 
_ 
�
�
й
Л
- ) 
С' 
у
�
С
i �
у
^
ыZ �
N 
�
у
tc 
н
'�, 
г
ь.'�.. 
ь. 
` 
�_ 
G 
у
n' 
. С
7 �О
С
О
�~.. 
�_с
- 
_V_ 
L 
У
7 
G 
��
. 
. �
а] 
:0 
L 
'.�
и
!�
О
й
�
^' 
3 д'r 
.�
v .5 � L 
�
^ 
� io ^ 
.с
F 
^ 
�
" 
С
'"' 
" 
" 
, с
а
'� с
с
° - 
�
к
�rv �ч
: 
ш
�' 
�"�
�
г- 
�
" 
�
�
С
,,, 
� ��
.�
�
'�
' 
й ь' �
- ^ �^�
1` 
�
z 4 
у г
У к
^°i R r 
а
�у
о- С ' 
�
С
а
7 
и I: г. ` �
г. и
с i г + а
^у�
л
- �
с
v 
^ �, �O ��
3 ., 
L й
;а
� �
�
�
� i ° : 
°
. 
'�
"' 
�
N. 
, 
�
н
> 
�
и
J-. 
г�
С
; 
V
� �
V 
'U 
с '! 
С . 
CL Lc1+
Ф
Х
�'-г
у ^ 
� - 
а
й
�
с on.S 
с
ё, а�
�
с
�
�
� �с
С
с
�
з: 
��
�
�
n. 
G 
�
... 
. 
. 
�_ 
` с
л
- �
�
�
й
. �
т
- 
�
?
;�
�
N 
> У
> . О
а`> L �v ы
° 
'>-� �
"' 
^ 
= 
G. �%о �ё
т
L. 
(^ 
�
U > 
S`. 
. �
> 
и
t 
7 
> 
�
J 
il 
' О
I J] 
L.
С
г
�
�
�
�
5 
v �
с
v v 
�
�v 
гO 
�
F Е
Е
�: 
5 
�= 4 С
i 
(" 
� �
у
�
-^ 
е
.-. 
N 
С
С
с
�
�+-�, 
С L 
,,��
' �
Г.. 
'Лч �
N 
�
�
i.�i 
У
у
О
�
'..�.. 
С0. 
.С
0. 
О
р
р
�
У
'U 
�> 
О
й
г
,
�
с�
г < 
^ r о о
у с У 3 v 
о - о w �
? 
�
`�' 
v у
О
,_ 
у
J 
О_ 
> 
оа �
сд
�
о
4 
^�
х
Г
с
i �
r' 
-r 
О
у
г,�
у
д
И
^ 
О
�0 
С
G 
,�
' О
С
С
С
�
. , 
�
',7 
^ 
м
�-ь�., 
у
�
�
v 
м
�Г
х
С
._ 
` 
а
.ы
. 
�
-�
4>'� N 
- �
�
О
:=�
,". 
У
ьУ. 
':э
i 
"!: 
� ] 
� ! 
�ai ��
�
С
�
С
�
С
j; 
� ;�
i 
� И
J 
т
У
т ? N 
s 
�� ._% ° 
С а
:,.. 
а. 
� 7` Е
�
;_-�, 
т
с. а
я.
1' 
о
��
_ 
Е
;�
т
и и
�
а N 
I- 
- 
" 
_ 
�^-- 
Ё Е
�? 
�
с � ыа �
" 
с _, 
., 
j, = v v �
j 
-
�
3, �
�
Л
,= 
и
;, 
�
i�
.�
�
_ 
^7 
а
у
й
г
�
.'^ 
" 
С
С
. С
. с
у
а�
U 
С
G 
б
. 
z 
s- 
^
�
'�, 
и
v 
v 
_ 
С
т �г, >' 
�
:D 
. 
�
�
й
_ 
" 
:Л
�
v 
у
v 
�
С
� � > 
�
j
�
�
у
л
�
��
С
�
и
:) 
:i 
G 
� , v v 
с
:v
т
¢ 
L 
� �.?'. 
к
�
. а
5.5 
= 
Е
� ,�
,о
, о
х
< 
о
_`° 
` 
с
У
У
л _^ 
Е
Е
_ 
'^ 
о
о
о
Q? 
� . 
_ 
�
Л
�
�
л т
° г ° с
а
с = n. 
:'v 
,�
_� о
^ о
�
й
�
�
�
�
_ �
с �
,-. �
~ �
" 
�
° 
а т
^ о
о
т
=_ 
_ 
о о` 
�
оо с
л
v 
ы о
о
о
Г ?, 
I �
�
q _с
^ 
�
а
' Е
У
и
.ы�, 
= �
а
�
� �� д
�
.с м
. 
^�
С4 
�
^^ 
у
С
С
С
G 
�
3 
-+ 
м
�
F гV 
�С
_^�
R :а
�
у
> � �
С
С
н
� �с
` 
" 
Е
.^, 
'J ^
F^ 
:Q 
Е
^J 
С
(д I �
J 
N �
L 
q 
Л
Е
�
�
�
' �
�
� �
_. . 
" . 
^ и �
г
_ ' - �
�
й
�. о, - �. 
й .,_
3: 
��
_. 
' 
_ 
�
�
у
° �
- 
�
Л
г
r � у
..
Е
�
�
� �� ,�
�
�
^ 
° 
с
'^ 
' 
r 
" 
у
.и,
i 
z 
��
- 
�
� �
�
�
'о �
о
� � � " 
о
�
v"' 
а
�
�
` � �
г
=_~ С
�
r
и с
у
�
�г
� �, 
Q 
г С с .�
�г
х
^ 
ь.7 
, : 
�
'{s 
� �.. 
а
�.t 
. 
,-,°'е ^ 
:+ �
С
. 
�
�
ь, 
У
ь
`�
i 
i` 
.�
�
С9 ^
�-' 
�
.�. �
�
i 
3
�
С
�+ 
�` 
i 
Q
. 
�_ Л
Gs; 
�_0 L�
` 
С
С� ; 
` 
а
�
�
�
I 
�
Q 
У
V! 
�
`'~О
С
'r 
�
'v 
z 
i 
Z 
`т,
�.7 
i
-т
vi
i 
_�
:
� J � й
4 �Е
�
��
;т, 
и
S1 
z 
1' 
�
с
j 
4 �
О
^ 
иа
. 
�
ш
,,,, 
' . 
: С
з
С У� S. й =_' с= 
° 
° 
q
�
... 
�С
>> 
Q 
v 
L 
ii 
�
с
J 
7
�^у . 
�
.
;�
_W N 
Ф
, �
1 �
-'�. 
Л
м
'�,Д, 
с
L.-
�
'J 
�' 
-',Jy 
х
G
�
;�
й N 
�
N 
�
7 
_ у
: 
.У ' 
Q 
N 
�
�
У
:6 
_л
А
! СЛ
й_ V.' 
а
�'�.
. _. S v ^7 Z 
... 
^J -r 
U
Ч
С
�
�
} 
.^Q f 
еа
' 
+ 
. �
.
'L ii 
у' 
с
a��i 
Е
з
I 
�
г
.! 
с
" 
�
_ 
"'^ 
'7 
F 
�
G�
TJ 
г
Й
. �
U
Л
� }
�
С
"� 7 
�_ 
,. л
; > м
°' 
"С�С' Сь
" 
�
�
�
's7 
N 
�С
G 
С
�р
Л
.,
г
о
а
x Q o 
� F г
у
f 
а
�
�
4_ 
°
_ 
л
г
_ 
�
� �
^О
_с
�р _ 
" 
гр
у
',aUr
F 
с.] 
>' 
м
у
.: 
ь. 
' 
с
. 
r 
5 
(i 
у' 
^vJ 
, 
J: 
�
с
�
. С
�
, U 
'�
^ 
ву, 
О
�
а
у 'г' 
с
г
д
р
ц
J^ 
�
,� ,�
Ё
ш
% 
4 
�
2 
�
V
�
�
R 
4 
С
i 
- 
',
�
�
> и
"с
�
�
"Е
�
, Е U v 
т
'й
.-_ 
с
�
�
�
Л - N �
а
`�
с
Е
� �O л
с �
� * 
'° 
� ��
�" �д Е � ? 
;; 
iб � :.. 
�
., 
b
z 
у� � о
О > v л у ; 
о Е
f.
� � �Л
�
Е
-
"а
N CJ Т�'J . Е �
�
� �а С, - �. U'v 
-- 
�
.
Z 
�
_ 
_ 
_ 
У
�
� : г1 } 
N 
�
с
'.Еб
�
'J 
у
'О
с
О
' 
С
М
Л
51 
'а. 
yi О
"^ д
�
'Л . 
:0 �_ 
О
г
q 
С
л
С
�
�
v.
р
�
�
О
г
д
Е
� 'w 
^ 
° ' 
`_' 
: �
3 L 
с
�' 
�
а °- Е
�
г- С
'*� � �
и �
j 
�
о, 3 R 
� ' у �
:а у
у v: а
- 
R 
�
�
� > �
�
�
� �
�
�
` � �
" о
° у
;°, 
� Ё
�
'- 
� f �
А
� _у н
�
� ia v :j 
й
г`s �
�
:`а а, �" 
�у с v �
� � � а
� ?° 
"-' 
а� ��"-.. 
�
" 
�о
о. �
Е
с
�
с '�
с
с
= 
z и
. 
,Х Q р
":ё �
' 
у
л
�
^ 
О
°_' �
к
Р: 
а
b е
а
л .9 = ... - �
.�
�
i 
�
�
пс'. Е
ci 
Л
- 
=
>' 
т -_ :s 
Е
с
а
у
z_ 
с ,с` 
`° 
' 
с �
;°_ 
= 
.�. г
r �
и
R.. 
�о '�
о
., 
G' 
л
ц�
т
� �
�
° 
3.
Е с `':, 
'
С .а � а
� �.- 
й v 
oz
�
j= 
.' �о
а
а`з
:о
�
L Z 
�
j 
у
� ' "�
U 
b 
с
.�
с
л
- 
ы
т
х
о
о
? 
�
� й
а г� с , s р. 
L 
�
л
<а
^ул
F с
_
�
Е
т
�
,`U, с
� и°. 
s 
с ,�
4 о
,�
�
с
v 
а у
у с_ �
'v �. 
е ai и_ �
� =v -и
�
а . �
:п �
�а л v с
а
с
с
_ 
и
Q 
с �
�
" 
с
Е У
t
� �
ь". � '= 
F 
аэ
"' 
у
^ О 'а
т N 
с. � S 
^.' с а
�
` 
�
`° �
`° 
а
ш
� ` 
> 
� ? 
�
О
.��
с
а ' �
л й
с
,. 
_ 
b<° 
v 
о у а
с �° 
,са '°
�
Е
у v
у
z 
л
а
. 
с . 
с
�
�. 
.�.. 
Е
л
л
а
с
и
а
��,��' 
N 
.�
С
L 
i 
л
J 
7�с1 
,-�^� . 
- 
Л
О
i 
О
iC 
С
�
�
,�. 
'д
�
«'�. 
�
L 
С
v 
�
v
.�
с� .О г
� �
у ��
�
Е ;� > 
v > bц `с
с
О �" п
с
�' � т
>
` 
Ы
Й
^ 
�U 
а
:0 
а
. 
N 
�1 
С
�Лг7 
у
а
F 
�
�
�
'i7 
�
й
^7 
._ 
�
"' 
й
С
�
с . 
л
.. 
�
S: 
�
TJ
�" 
^ о
й -7 �
�3 
с
.�
`. 
�
�
'
ги
�
Е,,, 
'' У' 
�
О
и
д
v 
,°+,
г ' 
�
t�- 
� г
i 
ш
�й
п
а
о
-0
�
сд, 
гл
s 
а
.� ' г
F 
�" о
v=_'O 
о
�
�
�
г
Q `г
�
�
-уг ` ` о
у М `- г
�
А
.`+о у �
° г
:i 
ао� i i С г с; о �
�
W 
�1 
Z. V 
�
'�е
Ч
Ci 
О
у
У
i' �
И
,,, 
и
�
б
С
о
G 
z 
�
�
е
�
F 
Q 
и`, 
со, �= 4 
г
�: 
� �
i 
.,7
�
r
J
JI
_ 
_ 
N
1 
L
�, д
�
' 
i 
,'�" 
_ 
Q 
! 
�'ll
� :,д
} 
И
�
�
:J 
л
у
Т
�^ 
�
'Л
Ф
`1+ 
ОС
,: с' 
_
�
г
; 
л
д
^ 
�-�
- 
О
�
г w i 
j а
� с
Е
г. 
С
� Е
�:
�
�
у
,' 
' 
��
�д
�
-' 
9 �
Z J 
� r 
�� v, 
уп
л
С
�
L 
�
�
�
v 
�
�
�
' 
у_r
�
�
у � г
С
_ � � С
.г
. 
�
в1 
S 
г�7 
� v 
i 
q 
�
С
9 
I"I. 
"! 
�
:б
~ �
О
�
. 
¢ "7 
�
-. 
. 
U 
.i 
�
�^ - 
. 
�в
N 
�
i ,.-�
�
J 
�
i 
�
�
�
�, а
- 
- 
р
; С . 
�, 
v 
.� , 
�
9} 
�С
j С
а�
�
'aqJ 
т
L 
v 
= 
у
л
�
й
�
л
. Х
�
`-
�
г
ь�<7 �
�
�
�
.7 
L 
J 
'`�7 
.�
Л
г'v` 
'J � �,,' 
Л
�
' �
. 
�
q 
�
Z 
�
,б
�
_ ]/ �. 
л
^' 
1 -' 
" 
�
о
и
> г.; 
1 �
�о
+% С
.�
� - 
'3 s 
=Л
^, ^] : 
:О
� � N 
_ 
L � �
�
-о
5 
�
Л
�
i :д
_. 
_ 
у] 
7 
т
О
'U 
�
J' 
� ' .,�,... 
�
Л
у
= �
i t 
¢ :а
� .с
-о i- � r �
.II
Q.' 
< 
г�.�
q 
.-. 
�
_ 
г
. �
I л
=. 
( �= 
й
А
i 9 
If
F 
�
л
у
�
' 
_ 
�
�
�' 
т
G�z. 
х
' 
Е
л
С
й
Е
i, 
�°- 
^ 
°>
. 
й
^ 
z 
< 
��
°с
-г. 
-,.7 
�
у 'ti �7 
л
и
а .
Lг: 
�
4] 
�, р
Г 7 
�
�
�
"С
`а
�
L 
I`, 
С
N
_ 
CL' 
r� � Т ' 
^ 
%" .�
'.J 
`е
Z г, 
`е
� .
_ 
Г ] 
N 
�
> N 
! ^ �
у
:�
'�
ь
С
" Е
�
.t- 
С
N
tz7 
�
у
�+ 
^ �7 
�
с
т
�= 
Е
b 
�
`� _ % �
';. 
У
-у
,у
_ 
га
�
v 
�
а�
Z 
N
� N 
j"' � �
Q �е
�
."с �
i- 
и
-с
з
s
. 
,_ 
е ~ 
! �' �
" 
_
�
�
�
у
i � гч
^_ 
" 
у
у
с
t 
�
I 
�у
�
r 
Ф
:. 
5 
�
�
о
Е
�, 
�
л
^ 
л �` � �
] 
5 
Z< 
�
" 
�_ 
О
�
-г,. 
�
л
у
�
- о
.vп
v = �- 
aJi
�
� , 
�, 
р
}i 
�U 
1-и- 
С
О_ 
... 
й. 
�
с
�
Z 
�
.'V �
С
`п
�! 
Х
. 
� ' 
�
�
.L 
'U 
.+м. 
м
�
:б
Л
�' 
L 
,L
�. 
i 
.С
= 
�
' 
Г 1 i 
�
р
, 
ш г�
�
�
л
.. 
'-' ° с �а
_ 
� �
у
Е v v: 
; 
"
'U
�
г N s 
ri; л
¢ b 
�
s-
о
�� _ л �- 
л
� а ~ �
I.-=, 
- 
�
1� �
�
------- 
1 
s
, 
I 
°- �
! 
s '',°
У
��
LL 
' 
у
С
'�
1 
�
�
_,
г
�
т
' 
с
од
о
; 
�� v 
�
,, 
. 
� , 
�, 
�
С
._ 
�' 
т
j ^ 
: 
. 
�
�
�
С
�
у
�
�
а
�
�с
�
�
�
,_ �
�
I 
�
у
�
1 
° " 
; 
, 
.7 
1 
s 
�
у г�
1 о й � � о
-O 
�
�
I 
1 
ti �г
�, 
]- о
о
�
с д
�
^�
�у � _., 
м
И
N 
�
Е
�
у
L 
й
' �
�
н
' �
.' �.. 
r�
�
. 
/'�
V 
. 
�.. 
- 
�и г гr: г и
Е :а �
�
- 
i �
�
� �
у
.�
�
�°
л
'v_ 
с
С
�
�
1: 
I = _ 
.�.^. �
^ а �с
' 
�
. �
.... 
... 
li 
L 
4 
L 
�
ti 
-
�
Е
�
Л
I 
v 
�
F 
�z 
и
.. 
:, 
у
... = 
^ 
л
г
у
�
�
_ '?. '�
'а
; 
� с
� < 
�
�, ���
� ''r�' 
° 
�
� �
�
" 
,л
Е
� ' 
_ � �' 
' 
� �
;г.. 
�
С
'о
v 'D 
�+ у
'O 
�" 
л
�
^1 �
r �
у
и
. � г
У�
�
�
�
= 
�
�1: 
'J
D 
А
�
.г�,`., s � о�о
�
1 
-:°
�
г�; 
° 
у
z° 
i 
�°о 1 й
°и
�
С , b
.,
^ У
�
�
' 
� � � ` 
` 
�
r С
^ 
�
�
��
с
'�
v 
с
г
` 
` 
�
г
1',
�
1 �
. 
�
-15-
SCHEDULE 4
Customized Amortization Repayment Schedule
The Borrower shall repay the principal amount of the Loan as follows:
Principal Payment Date 
Installment Share
May 15, 2024 
3.52%
November 15, 2024 
3J2%
May 15, 2025 
3.5%
November 15, 2025 
3.5%
May 15, 2026 
3.5%
November 15, 2026 
3.5%
May 15, 2027 
0.5%
November 15, 2027 
0.5%
May 15, 2028 
O.P,
November 15,2028 
0.5%
May 15, 2029 
0.5%
November 15, 2029 
0.5%
May 15, 2030 
1.165%
November 15. 2030 
1.165%
May 15, 2031 
1.165%
November 15, 2031 
1.165%
May 15, 2032 
1.165%
November 15, 2032 
1.165%
May 15, 2033 
1.165%
November 15, 2033 
1.165%
May 15, 2034 
3.5%
November 15,2034 
3.5%
May 15, 2035 
15%
November 15, 203 5 
3.5%
May 15, 2036 
3-5%
November 15, 2036 
-3.5%
May 15, 2037 
0.5%
November 15, 2037 
0.5%
May 15, 203 8 
0.5'!/o
November 15, 203 8 
0.5%
May 15, 2039 
0.5%
November 15, 203 9 
0.5%
May 15, 2040 
1.165%
November 15, 2040 
1.165%
May 15, 2041 
1.165%
November,l 5, 2041 
1.165%
May 15, 2042 
1.165%
November 15, 2042 
1 
1.165%
May 15, 2043 
4.64932%
November 15, 2043 
4.64932%
-16-
May 15, 2044 
3.5%
November 15, 2044 
3.5%
May 15, 2045 
3.50/%
November 15, 2045 
3.5%
May 15, 2046 
3.5%
November 15, 2046 
3.5%
May 15, 2047 
3.63887%
November 15, 2047 
1.54828%
May 15, 2048 
0.01517%
November 15, 2048 
0.01517%
May 15, 2049 
0.01517%
November 15, 2049 
0.01517%
May 15, 2050 
0.01517%
November 15, 2050 
0.01517%
May 15, 2051 
0.0122%
November 15, 2051 
0.0122%
May 15, 2052 
0.0122%
November 15, 2052 
0.0122%
May 15, 2053 
0.0122%
November 15, 2053 
0.01219%
-17-
APPENDIX
Definitions
1I 
"Anti-corruption Guidelines" means, for purposes of paragraph 5 of the Appendix to the
General Conditions, the Bank's "Guidelines on Preventing and Combating Fraud and
Corruption in Program-for-Results Financing," dated February 1, 2012, and revised July
10, 2015.
2. 
"Category" means a category set forth in the table in Section IV.A.2 of Schedule 2 to this
Agreement.
3. 
"DLMH" means the Program Implementing Entity's Directorate of Indian Medicine and
Homeopathy, or any successor thereto.
4. 
"Disbursement Linked Indicator" or "DLI" means each of the disbursement linked
indicators listed in the first column of the matrix set forth in Schedule 3 to this Agreement.
5. 
"Disbursement Linked Result" or "DLR" means in respect of a given DLI, the result under
said DLI as set forth in the matrix in Schedule 3 to this Agreement, on the basis of the
achievement of which, the amount of the Loan allocated to said result may be withdrawn
in accordance with the provisions of Section IV of Schedule 2 to this Agreement.
6. 
"DME" means the Program Implementing Entity's Directorate of Medical Education, or
any successor thereto.
7. 
"DMRHS" means the Program Implementing Entity's Directorate of Medical and Rural
Health Services, or any successor thereto.
8. 
"DoF" means Tamil Nadu's Department of Finance, or any successor thereto.
9. 
"DoHFW" means Tamil Nadu's Department of Health and Family Welfare, or any
successor thereto.
10. 
"DPH" means the Program Implementing Entity's Directorate of Public Health, or any
successor thereto.
I1. 
"Empowered Committee" or "EC" means the committee referred to in Section I.B. 1(b) of
the Schedule to the Program Agreement.
12. 
"ESSA" means the Environmental and Social Systems Assessment, disclosed on
November 19, 2018 setting forth the description of the Program's activities, assessing the
Borrower's and Program Implementing Entity's environmental and social management
systems, detailing the Program's environmental and social benefits, risks and impacts, and
recommending remedial measures to strengthen the social and environmental systems
performance.
-18-
13. 
"Fiscal Year" or "FY" means the Borrower's fiscal year, which begins on April I of each
calendar year and ends of March 31 of the next calendar year.
14. 
"General Conditions" means the "International Bank for Reconstruction and Development
General Conditions for IBRD Financing, Program-for-Results Financing", dated July 14,
2017.
15. 
"Group A Facility" means an advanced trauma center that provides a wide set of surgeries
including general, orthopedic, plastic. vascular and neuro surgeries.
16. 
"Group B Facility" means a basic trauma center that provides a limited set of surgeries
including general and orthopedic surgeries.
17. 
"Health Facilities" collectively refers to Primary Care Facilities, Secondary Care Facilities
and Tertiary Care Facilities.
18 
"HMIS" means the Program Implementing Entity's health management information
system.
19. 
Independent Verification Agent" or "IVA" means the agent appointed, or to be appointed,
by the Program Implementing Entity for the purpose of verifying achievement of DLRs in
accordance with Section I.D of the Schedule to the Program Agreement.
20. 
"NABH" means the Borrower's National Accreditation Board for Hospitals & Healthcare
Providers, or its successor thereto.
21. 
"NCD" means non-communicable disease, and includes hypertension, diabetes, cervical
cancer, breast cancer, oral cancer and mental health related disease.
22. 
"NHM" means the Program Implementing Entity's National Health Mission, or any
successor thereto.
23. 
"NQAS" means the National Quality Assurance Standards developed by the Borrower's
Ministry of Health and Family Welfare to assess and provide quality certification to public
health facilities.
24. 
"Primary Care Facility" means a health facility where health professionals act as a first
point of consultation for all patients, including Primary Health Centers and community
health centers.
25. 
"Primary Health Centers" means a health facility designated as a PHC by Tamil Nadu.
26. 
"Priority District(s)" means any of the Program Implementing Entity's districts of Ariyalur,
Dharmapuri, 
Ramanathapuram. 
The 
Nilgris, 
Theni, 
Thoothukkudi, 
Tirunelveli,
Tiruvannamalai and Virudhunagar, as such list may be modified with prior concurrence of
the Bank.
-19-
27 
"Program Action Plan" means the Borrower's plan dated February 5. 2019 and referred to
in Section I.B of Schedule 2 to this Agreement, as may be amended from time to time with
the agreement of the Bank.
28. 
"Program Implementing Entity" means the Borrower's state of Tarmil Nadu.
29. 
"Program Management Unit" or "PMU"' means the unit referred to in Section I.B. 1(a) of
the Schedule to the Program Agreement.
30. 
"Program Steering Committee" or "PSC" means the committee referred to in Section
LB. 1(c) of the Schedule to the Program Agreement.
31. 
"Secondary Care Facility" means a health facility providing acute care or necessary
treatment for a short period of time for a brief but serious illness, injury, or other health
condition, including district headquarter, taluk and non-taluk hospitals.
32. 
"Signature Date" means the later of the two dates on which the Borrower and the Bank
signed this Agreement and such definition applies to all references to "the date of the Loan
Agreement" in the General Conditions.
33. 
"STEPS Survey" means a survey using the stepwise approach to surveillance methodology
developed by the World Health Organization to enable Tamil Nadu to develop its own
surveillance system to monitor and fight against NCDs.
34. 
"Tamil Nadu" means the Borrower's state of Tamil Nadu.
35. 
"Tertiary Care Facility" means a specialized consultative health care facility, usually for
inpatients and on referral from a Primary Care Facility or Secondary Care Facility,
including a medical college.
36. 
"TNFSDA" means the Program Implementing Entity's Tamil Nadu Food Safety and Drug
Administration, or any successor thereto.
37. 
"TNHSP Society" means the Program Implementing Entity's Tamil Nadu Health Systems
Project Society, or any successor thereto.
38. 
"TNMSC" means the Program Implementing Entity's Tamil Nadu Medical Services
Corporation, or any successor thereto.
